Metformin: all 1,377 studies that test it
Page 10 of 14. Open to participants first (169), then studies with results posted, then the rest; newest registration first within each.
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and MetforminCompletedNCT02760342Phase 1
- Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsCompletedNCT02755844Phase 1/2
- Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 DiabetesCompletedNCT02752113Phase 3
- Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic AbnormalitiesCompletedNCT02751307Phase 4
- Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy ParticipantsCompletedNCT02745912Phase 1
- Coronary Artery Disease Progression in Patients With PrediabetesCompletedNCT02744976Phase 4
- The Effect of Metformin on Reducing Lupus FlaresCompletedNCT02741960Phase 4
- Response of Individuals With Ataxia-Telangiectasia to Metformin and PioglitazoneCompletedNCT02733679Phase 4
- Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy VolunteersCompletedNCT02712619Phase 1
- May Metformin be Used in Renal Failure?CompletedNCT02710448Phase 2
- SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitisCompletedNCT02696941Phase 1
- Effects of Metformin in Heart Failure PatientsWithdrawnNCT02694289Not applicable
- Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOSCompletedNCT02689843Early Phase 1
- Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or PlaceboCompletedNCT02682121Phase 1
- Metformin Plus Sorafenib for Advanced HCCStatus unknownNCT02672488Phase 2
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered AloneStatus unknownNCT02670018Phase 1
- Metformin Immunotherapy in HIV InfectionCompletedNCT02659306Phase 1
- Assessing the Efficacy and Safety of Metformin in Treatment of Moderate PsoriasisStatus unknownNCT02644954Phase 3
- Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder PatientsCompletedNCT02644577Phase 4
- Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide AloneTerminatedNCT02640534Phase 2
- Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic SyndromeCompletedNCT02629627Phase 2
- Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal CancerStatus unknownNCT02614339Phase 3
- A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy ParticipantsCompletedNCT02611518Phase 1
- Initial Combination of Gemigliptin and Metformin on Microbiota ChangeCompletedNCT02609815Not applicable
- Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 DiabetesStatus unknownNCT02605772Phase 4
- Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DMCompletedNCT02597400Phase 1
- Impact of OCT1 on Metformin ToleranceCompletedNCT02586636Phase 4
- Continuation of Metformin to Improve And Keep Peri-operative Glycemic ControlWithdrawnNCT02571608Phase 4
- The Effect of Metformin on Different Hormones in PCOS PatientsCompletedNCT02568488Phase 4
- Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome PatientsCompletedNCT02562664Phase 2
- Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 DiabetesStatus unknownNCT02548741Not applicable
- The Effect of Metformin on Composition of Human Gut BacteriaCompletedNCT02546050Phase 1
- The Effects of Metformin in Patients With Mild Graves' OphthalmopathyStatus unknownNCT02535975Not applicable
- Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin TreatmentStatus unknownNCT02535299Phase 4
- Effects of Rosiglitazone and Metformin on Metabolism in Type 2 DiabetesCompletedNCT02526615Phase 4
- Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin ResistantTerminatedNCT02523898Phase 2
- Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar DisorderCompletedNCT02519543Phase 3
- Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and MetforminCompletedNCT02516085Phase 1
- Testosterone, Metformin, or Both, for Hypogonadism in Obese MalesCompletedNCT02514629Phase 3
- Metformin And LongevityStatus unknownNCT02511665Phase 4
- Phase 1 Bioavailability Study of SYR-322METCompletedNCT02508168Phase 1
- Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast CancerStatus unknownNCT02506790Phase 2
- Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.Status unknownNCT02506777Phase 2
- Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose ToleranceStatus unknownNCT02502344Phase 4
- LIpitor and biGuanide to Androgen Delay TrialWithdrawnNCT02497638Phase 2
- Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 DiabetesCompletedNCT02497313Not applicable
- A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast CancerCompletedNCT02488564Phase 2
- Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary SyndromeCompletedNCT02483299Phase 4
- Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal CancerTerminatedNCT02473094Phase 2
- Metformin Experience on Minimal Hepatic EncephalopathyStatus unknownNCT02470546Phase 4
- Metformin and Congenital Nephrogenic Diabetes InsipidusTerminatedNCT02460354Phase 1
- Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot StudyWithdrawnNCT02457286Phase 1
- Research of Intensive Lifestyle Intervention for PCOS Patients With IGTCompletedNCT02446834Not applicable
- Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With ObesityStatus unknownNCT02438020Phase 4
- Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian CarcinomaStatus unknownNCT02437812Phase 2
- Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.CompletedNCT02437656Phase 2
- Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) PatientsCompletedNCT02411825Phase 1
- Insulin Resistance and Mild Cognitive Impairment (IRMCI) StudyTerminatedNCT02409238Phase 4
- Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and AnoikisTerminatedNCT02402348Early Phase 1
- The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized TrialCompletedNCT02394652Phase 2
- Preventing Recurrent Gestational Diabetes With MetforminStatus unknownNCT02394158Phase 4
- Attenuating The Post-Operative Insulin Resistance And Promoting Protein AnabolismTerminatedNCT02393573Not applicable
- Metformin for HIV InflammationStatus unknownNCT02383563Phase 2
- Simvastatin and Metformin in Chronic PeriodontitisCompletedNCT02372656Phase 2/3
- Metformin and Simvastatin Use in Bladder CancerStatus unknownNCT02360618Phase 2
- Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate CancerCompletedNCT02339168Phase 1
- Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by SurgeryActive, not recruitingNCT02336087Phase 1
- Effects of Metformin in Pre-frail ElderlyStatus unknownNCT02325245Phase 3
- Primary Prevention Hepatocellular Carcinoma by MetforminTerminatedNCT02319200Phase 3
- Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian CancerCompletedNCT02312661Phase 1
- Improving Fibrosis Outcomes With MetforminWithdrawnNCT02306070Phase 2
- Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary SyndromeCompletedNCT02302326Not applicable
- Platelet Rich Fibrin With 1% Metformin Gel for Treatment of Intrabony DefectsCompletedNCT02283554Phase 2
- Trial With Metformin in Women With Polycystic Ovary SyndromeCompletedNCT02280057Phase 4
- A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine TumorsStatus unknownNCT02279758Phase 2
- Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast CancerCompletedNCT02278965Phase 1
- Medico-GDM Trial - Metformine to Prevent Gestational Diabetes MellitusCompletedNCT02275845Phase 3
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic PatientsTerminatedNCT02274740Phase 2
- 1% Metformin in Moderate and Severe PeriodontitisCompletedNCT02274090Phase 2/3
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical UnitWithdrawnNCT02250794Phase 4
- Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy SubjectsCompletedNCT02249910Phase 1
- Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome WomenStatus unknownNCT02244567Phase 1
- Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin ResistanceCompletedNCT02234440Not applicable
- Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and RosuvastatinCompletedNCT02231931Phase 1
- Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy VolunteersCompletedNCT02221414Phase 1
- Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy VolunteersCompletedNCT02221401Phase 1
- Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02221180Phase 1
- Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy VolunteersCompletedNCT02220647Phase 1
- Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted ParticipantsCompletedNCT02220218Phase 1
- Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated TabletWithdrawnNCT02217670Phase 1
- Pharmacokinetic Profiles of Metformin With DW1029MCompletedNCT02212756Phase 1
- Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on CancerWithdrawnNCT02201381Phase 3
- Metformin Treatment in Polycystic Ovary Syndrome (PCOS)Status unknownNCT02198417Not applicable
- Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated MelanomaTerminatedNCT02190838Phase 2
- Metformin in Psoriatic ArthritisCompletedNCT02188654Not applicable
- PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary SyndromeCompletedNCT02187250Phase 4
- Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and RosuvastatinCompletedNCT02186483Phase 1
- Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female SubjectsCompletedNCT02173639Phase 1
- Relative Bioavailability BI 10773 and Metformin in Healthy Male VolunteersCompletedNCT02172248Phase 1
- Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic CancerCompletedNCT02153450Early Phase 1